Direkt zum Inhalt
Merck

Optimized protocol to detect protein UFMylation in cells and in vitro via immunoblotting.

STAR protocols (2022-01-18)
Junzhi Zhou, Qian Liang, Maogong Dong, Xiaohe Ma, Yaqi Jin, Di Guan, Jiang Liu, Miao Wang, Yu-Sheng Cong
ZUSAMMENFASSUNG

Ubiquitin-fold modifier 1 (UFM1) system is a recently identified ubiquitin-like modification with essential biological functions. Similar to ubiquitination, the covalent conjugation of UFM1 (UFMylation) to target proteins involves a three-step enzymatic cascade catalyzed sequentially by UFM1-activating enzyme 5 (UBA5, E1), UFM1-conjugating enzyme 1 (UFC1, E2), and UFM1-specific ligase 1 (UFL1, E3). Here, we provide an optimized protocol adapted to previously reported methods for detecting the UFMylation of target protein in human cells and in vitro assays, respectively, with high reliability and reproducibility. For complete details on the use and execution of this protocol, please refer to Liu et al. (2020).

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Millipore
ANTI-FLAG® M2-Affinitätsgel, purified immunoglobulin, buffered aqueous glycerol solution
Millipore
ANTI-FLAG® in Kaninchen hergestellte Antikörper, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-Maus-IgG (Gesamtmolekül)-Peroxidase in Kaninchen hergestellte Antikörper, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-Kaninchen-IgG-(Gesamtmolekül)-Peroxidase in Ziege hergestellte Antikörper, IgG fraction of antiserum, buffered aqueous solution